papaverine has been researched along with Priapism in 79 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
Priapism: A prolonged painful erection that may lasts hours and is not associated with sexual activity. It is seen in patients with SICKLE CELL ANEMIA, advanced malignancy, spinal trauma; and certain drug treatments.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of our work is to evaluate the efficacy of intracavernous sodium nitroprusside (SNP) in management of erectile dysfunction (ED) in a clinical comparative study with papaverine/phentolamine in ED patients." | 9.11 | Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects. ( Abdelsalam, W; Atteya, A; Elnashaar, A; Gadallah, A; Shamloul, R; Zohdy, W, 2005) |
| "Intracorporeal administration of papaverine hydrochloride is frequently used in the diagnosis and treatment of impotence." | 8.78 | Risk factors for papaverine-induced priapism. ( Jarow, JP; Lomas, GM, 1992) |
| "To analyze the predictive factors causing ischemic priapism following penile doppler ultrasonography (PDU) with intracavernosal papaverine injection Materials and methods: Medical records of 467 patients who underwent PDU examination following intracavernosal papaverine injection for erectile dysfunction (ED) between 2009 and 2017 were retrospectively reviewed." | 7.96 | Independent Predictive Factors for Occurrence of Ischemic Priapism after Papaverine Injection. ( Erbin, A; Güler, Y, 2020) |
| "The autors recommend intravenous methylene blue for the treatment of priapism." | 7.72 | Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. ( Hübler, J; Könyves, K; Szántó, A, 2003) |
| "We identified color Doppler sonography findings that are useful for predicting priapism in patients after the intracavernous injection of diagnostic papaverine." | 7.71 | The prediction of papaverine induced priapism by color Doppler sonography. ( Arslan, D; Dicle, O; Esen, AA; Goktay, AY; Pirnar, T; Secil, M, 2001) |
| "The effectiveness and complications of intracorporeal phenylephrine without aspiration or irrigation as a treatment for priapism were assessed." | 7.69 | Intracorporeal phenylephrine in the treatment of priapism. ( Hosking, DH; Muruve, N, 1996) |
| "A case of priapism following oral intake of papaverine hydrochloride (300 mg) is reported." | 7.69 | Priapism following ingestion of papaverine tablets. ( el-Sherif, A; Prasad, K, 1996) |
| "Priapism occurred in ten patients undergoing treatment of depression with trazodone or impotence with papaverine." | 7.68 | Pharmacological priapism: comparison of trazodone- and papaverine-associated cases. ( Bardin, ED; Krieger, JN, 1990) |
| "Pharmacological prolonged erections or priapism due to anesthesia were treated in 36 patients with intracorporeal injections of phenylephrine." | 7.68 | Treatment of pharmacological priapism with phenylephrine. ( Albrecht, K; Bar-Moshe, O; Dittrich, A; Vandendris, M, 1991) |
| " orally) for persistent penile erection and priapism resulting from injection of pharmacological agents, such as phentolamine, phenoxybenzamine and papavarine, into the penis for erectile impotence." | 7.67 | Treatment of persistent penile erection and priapism using terbutaline. ( Finnerty, DP; Rodriquez, AP; Shantha, TR, 1989) |
| "In 5 out of 84 patients suffering from impotence a prolonged erection was observed after intracavernous papaverine injection." | 7.67 | [Priapism as a complication following diagnostic papaverine test]. ( Darewicz, J; Galek, L, 1989) |
| "Ten patients with priapism after self-administered intracavernous papaverine injection for erectile impotence had to be treated as emergencies between September 1985 and February 1988." | 7.67 | [Papaverine-induced priapism. Experiences with a new urologic emergency]. ( Busch, R; Gonnermann, D; Klosterhalfen, H; Schneider, AW, 1989) |
| "This finding is reliable enough that treatment for priapism should be initiated without further delay." | 5.33 | Intracavernous papaverine/phentolamine-induced priapism can be accurately predicted with color Doppler ultrasonography. ( Abdul-Wahab, M; El-Nashar, AR; Gad-Allah, A; Metawea, B; Shamloul, R, 2005) |
| "Priapism is a recognized complication of intracavernous self-injection of vasoactive agents for the management of impotence." | 5.28 | Heterotopic bone formation in the corpus cavernosum: a complication of papaverine-induced priapism. ( Lue, TF; Vapnek, J, 1989) |
| " Use of low dosage of papaverine is suggested as an additional mode of therapy in the management of psychogenic impotence." | 5.28 | Intracavernous papaverine in the management of psychogenic impotence. ( Bhutwala, A; Dhabuwala, CB; Kerkar, P; Kumar, A; Pierce, JM, 1990) |
| "Priapism was not encountered during self-injection but it did occur twice in 329 physician-administered injections." | 5.28 | Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. ( Althof, SE; Bodner, DR; Kursh, ED; Levine, SB; Resnick, MI; Risen, CB; Turner, LA, 1989) |
| " A total of 400 patients with erectile dysfunction were evaluated before and after diagnostic intracavernous injection of a trimix solution (papaverine+phentolamine+PGE1) using color Doppler sonography." | 5.11 | The value of penile duplex in the prediction of intracavernous drug-induced priapism. ( Ghanem, HM; Kamel, II; Mousa, AA; Salem, A; Shamloul, R, 2004) |
| "The aim of our work is to evaluate the efficacy of intracavernous sodium nitroprusside (SNP) in management of erectile dysfunction (ED) in a clinical comparative study with papaverine/phentolamine in ED patients." | 5.11 | Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects. ( Abdelsalam, W; Atteya, A; Elnashaar, A; Gadallah, A; Shamloul, R; Zohdy, W, 2005) |
| "Intracorporeal administration of papaverine hydrochloride is frequently used in the diagnosis and treatment of impotence." | 4.78 | Risk factors for papaverine-induced priapism. ( Jarow, JP; Lomas, GM, 1992) |
| "Intracavernous administration of papaverine and phentolamine has become an essential and indispensible element in the diagnosis and treatment of erectile dysfunction." | 4.77 | How safe is the treatment of impotence with intracavernous autoinjection? ( Ludwig, G; Zentgraf, M; Ziegler, M, 1989) |
| "To analyze the predictive factors causing ischemic priapism following penile doppler ultrasonography (PDU) with intracavernosal papaverine injection Materials and methods: Medical records of 467 patients who underwent PDU examination following intracavernosal papaverine injection for erectile dysfunction (ED) between 2009 and 2017 were retrospectively reviewed." | 3.96 | Independent Predictive Factors for Occurrence of Ischemic Priapism after Papaverine Injection. ( Erbin, A; Güler, Y, 2020) |
| "Patients with organic and mixed impotence are best suited for injection treatment, but selected patients with psychogenic impotence also benefit from therapy." | 3.76 | Injection therapy for impotence. ( Althof, SE; Bodner, DR; Kursh, ED; Levine, SB; Resnick, MI; Risen, C; Turner, L, 1988) |
| "The autors recommend intravenous methylene blue for the treatment of priapism." | 3.72 | Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. ( Hübler, J; Könyves, K; Szántó, A, 2003) |
| "Herein we describe the use of intracavernous methylene blue (MB), a guanylate cyclase inhibitor, or internal pudendal artery embolization for the treatment of priapism." | 3.70 | Alternative approaches to the management of priapism. ( Angle, JF; deHoll, JD; Shin, PA; Steers, WD, 1998) |
| "The effectiveness and complications of intracorporeal phenylephrine without aspiration or irrigation as a treatment for priapism were assessed." | 3.69 | Intracorporeal phenylephrine in the treatment of priapism. ( Hosking, DH; Muruve, N, 1996) |
| "Intracavernosal administration of papaverine or prostaglandin E1 for erectile impotence in paraplegics is being practised widely." | 3.69 | Management of pharmacologically induced prolonged penile erection with oral terbutaline in traumatic paraplegics. ( Krishnan, KR; Soni, BM; Vaidyanathan, S, 1994) |
| "Treatment of priapism with intracavernous alpha-adrenergic agonist vasoconstrictor agents is well accepted, particularly for patients with priapism secondary to intracavernous injections of papaverine, phentolamine and/or prostaglandin E1." | 3.69 | Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism. ( Cannon, B; Lee, M; Sharifi, R, 1995) |
| "Using papaverine, papaverine/phentolamine, or prostaglandin E1 (PGE1), intracavernosal pharmacotherapy has been successful in treating erectile dysfunction." | 3.69 | Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction. ( Chao, R; Clowers, DE, 1994) |
| "A case of priapism following oral intake of papaverine hydrochloride (300 mg) is reported." | 3.69 | Priapism following ingestion of papaverine tablets. ( el-Sherif, A; Prasad, K, 1996) |
| "Priapism occurred in ten patients undergoing treatment of depression with trazodone or impotence with papaverine." | 3.68 | Pharmacological priapism: comparison of trazodone- and papaverine-associated cases. ( Bardin, ED; Krieger, JN, 1990) |
| "Pharmacological prolonged erections or priapism due to anesthesia were treated in 36 patients with intracorporeal injections of phenylephrine." | 3.68 | Treatment of pharmacological priapism with phenylephrine. ( Albrecht, K; Bar-Moshe, O; Dittrich, A; Vandendris, M, 1991) |
| "The authors present the seamy side of the beneficial practice to handle erectile impotence with papaverine or with the papaverine-Regitin combination." | 3.68 | Induced priapism and its management. ( Götz, F; Jilling, A; Török, A, 1991) |
| "From 1986 to 1989 papaverine was used alone or in combination with phentolamine in 165 patients in diagnosis and treatment of erectile dysfunction." | 3.68 | [Priapism following intracavernous injection of vasoactive substances as a urologic emergency]. ( Papadopoulos, I; Wand, H; Weichert-Jacobsen, K, 1990) |
| "In erectile dysfunction formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination papaverine/phentolamine were employed." | 3.68 | [Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities]. ( Schrey, A, 1990) |
| " The former group (which has papaverine as leader) produces a significant number of side effects, not least of these being priapism; there is a risk of lasting iatrogenic impotence which is not negligible." | 3.67 | [Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Defense for the use of facilitating drugs. Part I--Pharmacology, classification and complications of active drugs]. ( Buvat, J; Buvat-Herbaut, M; Lemaire, A; Marcolin, G, 1989) |
| " orally) for persistent penile erection and priapism resulting from injection of pharmacological agents, such as phentolamine, phenoxybenzamine and papavarine, into the penis for erectile impotence." | 3.67 | Treatment of persistent penile erection and priapism using terbutaline. ( Finnerty, DP; Rodriquez, AP; Shantha, TR, 1989) |
| "In 5 out of 84 patients suffering from impotence a prolonged erection was observed after intracavernous papaverine injection." | 3.67 | [Priapism as a complication following diagnostic papaverine test]. ( Darewicz, J; Galek, L, 1989) |
| "Priapism is an alarming complication during treatment of erectile dysfunction with vasoactive drugs, particularly papaverine alone or in combination with phentolamine mesylate." | 3.67 | Priapism: an avoidable complication of pharmacologically induced erection. ( Beddoe, E; Binik, YM; Elhilali, MM; Fouda, A; Hassouna, M; Kalogeropoulos, D, 1989) |
| "Ten patients with priapism after self-administered intracavernous papaverine injection for erectile impotence had to be treated as emergencies between September 1985 and February 1988." | 3.67 | [Papaverine-induced priapism. Experiences with a new urologic emergency]. ( Busch, R; Gonnermann, D; Klosterhalfen, H; Schneider, AW, 1989) |
| "A total of 78 patients 17 to 84 years old reported their experience via questionnaire with the papaverine-phentolamine injection technique for impotence." | 3.67 | Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients. ( Bruskewitz, RC; Feyzi, J; Gasser, TC; Girdley, FM; Graversen, PH, 1988) |
| " papaverine) for the treatment of erectile dysfunction." | 3.67 | Prolonged erections following intracorporeal injection of medications to overcome impotence. ( Carati, CJ; Earle, CM; Keogh, EJ; Lord, DJ; Tulloch, AG; Watters, GR; Wisniewski, ZS, 1988) |
| "We report on our results with the intracavernous injection and self-injection of papaverine-phentolamine in a group of spinal cord injury patients with erectile impotence." | 3.67 | Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients. ( Claessens, H; de Meyer, JM; de Sy, WA; Wyndaele, JJ, 1986) |
| "Clearly, the choice of therapy for impotence must now be made on an individual basis after a careful diagnostic evaluation and in-depth consultation with the patient." | 2.37 | New therapy for impotence. ( Lue, TF; Orvis, BR, 1987) |
| "The incidence of priapism has fallen with the introduction of prostaglandin E1 monotherapy as the favoured drug for ICI therapy of erectile failure." | 1.32 | The incidence and management of priapism in Western Australia: a 16 year audit. ( Ching, HL; Earle, CM; Stuckey, BG; Wisniewski, ZS, 2003) |
| "Priapism is always a potential phenomenon where no individual, no particular drug and no specific dose are completely safe." | 1.31 | The incidence of pharmacologically induced priapism in the diagnostic and therapeutic management of 685 men with erectile dysfunction. ( Athanasopoulos, A; Barbalias, G; Geramoutsos, I; Perimenis, P, 2001) |
| "Scarring was documented in one patient." | 1.29 | Intracavernous self-injection of papaverine and verapamil: a clinical experience. ( Bolayir, K; Gökşin, N, 1994) |
| "The aetiology of impotence was psychogenic in > 50% of the patients (13/24)." | 1.29 | Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs. ( Kulmala, RV; Tamella, TL, 1995) |
| "Scarring was documented in 7 of 170 patients (4." | 1.29 | Experience with triple-drug therapy in a pharmacological erection program. ( Gibbons, RP; Govier, FE; Kramer-Levien, D; McClure, RD; Pritchett, TR; Weissman, RM, 1993) |
| "Priapism is a recognized complication of intracavernous self-injection of vasoactive agents for the management of impotence." | 1.28 | Heterotopic bone formation in the corpus cavernosum: a complication of papaverine-induced priapism. ( Lue, TF; Vapnek, J, 1989) |
| " Use of low dosage of papaverine is suggested as an additional mode of therapy in the management of psychogenic impotence." | 1.28 | Intracavernous papaverine in the management of psychogenic impotence. ( Bhutwala, A; Dhabuwala, CB; Kerkar, P; Kumar, A; Pierce, JM, 1990) |
| "Priapism was not encountered during self-injection but it did occur twice in 329 physician-administered injections." | 1.28 | Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. ( Althof, SE; Bodner, DR; Kursh, ED; Levine, SB; Resnick, MI; Risen, CB; Turner, LA, 1989) |
| " A further advantage of the method is the lower dosage required, which means that the gonads are exposed to less radiation." | 1.28 | [Cavernosography using digital luminescence radiography (DLR) in the diagnosis of venous induced erectile function and of diseases of the corpus cavernosum]. ( Christiansen, GR; Marks, W; Papadopoulos, I; Weichert-Jacobsen, K, 1991) |
| "Priapism was the most significant complication and occurred in 8." | 1.27 | Pharmacological erection: diagnosis and treatment applications in 69 patients. ( Ellis, LR; Kramer-Levien, D; Nellans, RE, 1987) |
| "Lastly, they represent a new treatment for priapism." | 1.27 | [Intracavernosa injections of drugs in erection disorders. Their clinical value apropos of 100 cases]. ( Bondil, P; Mazeman, E; Nguyen Qui, JL; Rigot, JM, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (44.30) | 18.7374 |
| 1990's | 31 (39.24) | 18.2507 |
| 2000's | 10 (12.66) | 29.6817 |
| 2010's | 2 (2.53) | 24.3611 |
| 2020's | 1 (1.27) | 2.80 |
| Authors | Studies |
|---|---|
| Güler, Y | 1 |
| Erbin, A | 1 |
| Sönmez, MG | 1 |
| Öztürk Sönmez, L | 1 |
| Taşkapu, HH | 1 |
| Kara, C | 1 |
| Dündar, ZD | 1 |
| Göğer, YE | 1 |
| Evrin, T | 1 |
| Öztürk, A | 1 |
| Kilic, M | 1 |
| Serefoglu, EC | 1 |
| Ozdemir, AT | 1 |
| Balbay, MD | 1 |
| Earle, CM | 2 |
| Stuckey, BG | 1 |
| Ching, HL | 1 |
| Wisniewski, ZS | 2 |
| McMahon, CG | 1 |
| Shamloul, R | 3 |
| Ghanem, HM | 1 |
| Salem, A | 1 |
| Kamel, II | 1 |
| Mousa, AA | 1 |
| Priyadarshi, S | 1 |
| Hübler, J | 1 |
| Szántó, A | 1 |
| Könyves, K | 1 |
| Metawea, B | 1 |
| El-Nashar, AR | 1 |
| Gad-Allah, A | 1 |
| Abdul-Wahab, M | 1 |
| Atteya, A | 1 |
| Elnashaar, A | 1 |
| Gadallah, A | 1 |
| Zohdy, W | 1 |
| Abdelsalam, W | 1 |
| Muruve, N | 1 |
| Hosking, DH | 1 |
| Kulmala, RV | 1 |
| Tamella, TL | 1 |
| Bolayir, K | 1 |
| Gökşin, N | 1 |
| Meinhardt, W | 1 |
| Lycklama à Nijeholt, AA | 1 |
| Kropman, RF | 1 |
| Vermeij, P | 1 |
| Zwartendijk, J | 1 |
| Soni, BM | 1 |
| Vaidyanathan, S | 1 |
| Krishnan, KR | 1 |
| Lee, M | 1 |
| Cannon, B | 1 |
| Sharifi, R | 1 |
| Buvat, J | 2 |
| Buvat-Herbaut, M | 2 |
| Lemaire, A | 2 |
| Marcolin, G | 2 |
| Valdevenito, R | 1 |
| Melman, A | 1 |
| Chao, R | 1 |
| Clowers, DE | 1 |
| Govier, FE | 1 |
| McClure, RD | 1 |
| Weissman, RM | 1 |
| Gibbons, RP | 1 |
| Pritchett, TR | 1 |
| Kramer-Levien, D | 2 |
| Millard, RJ | 1 |
| Stricker, PD | 1 |
| Lynch, WJ | 1 |
| Dean, TE | 1 |
| Murnaghan, GF | 1 |
| Breslin, FH | 1 |
| Prasad, K | 1 |
| el-Sherif, A | 1 |
| deHoll, JD | 1 |
| Shin, PA | 1 |
| Angle, JF | 1 |
| Steers, WD | 1 |
| Baniel, J | 1 |
| Israilov, S | 1 |
| Engelstein, D | 1 |
| Shmueli, J | 1 |
| Segenreich, E | 1 |
| Livne, PM | 1 |
| Perimenis, P | 1 |
| Athanasopoulos, A | 1 |
| Geramoutsos, I | 1 |
| Barbalias, G | 1 |
| Secil, M | 1 |
| Arslan, D | 1 |
| Goktay, AY | 1 |
| Esen, AA | 1 |
| Dicle, O | 1 |
| Pirnar, T | 1 |
| Morales Concepción, JC | 1 |
| Parfitt, VJ | 1 |
| Wong, R | 1 |
| Dobbie, A | 1 |
| Hartog, M | 1 |
| Gingell, JC | 1 |
| Lomas, GM | 1 |
| Jarow, JP | 1 |
| Vale, JA | 1 |
| Kirby, RS | 1 |
| Lees, W | 1 |
| Virag, R | 1 |
| Leliefeld, HH | 1 |
| Peulen, GJ | 1 |
| Dittrich, A | 1 |
| Albrecht, K | 1 |
| Bar-Moshe, O | 1 |
| Vandendris, M | 1 |
| Török, A | 2 |
| Jilling, A | 2 |
| Götz, F | 2 |
| Rajmil, O | 1 |
| García, F | 1 |
| Fabián, E | 1 |
| Bassas, L | 1 |
| Pomerol, JM | 1 |
| Schwarzer, JU | 1 |
| Hofmann, R | 1 |
| Adaikan, PG | 1 |
| Lau, LC | 1 |
| Vasatha, KS | 1 |
| Susheela, K | 1 |
| Ratnam, SS | 1 |
| Hashmat, AI | 1 |
| Abrahams, J | 1 |
| Fani, K | 1 |
| Nostrand, I | 1 |
| Papadopoulos, I | 2 |
| Marks, W | 1 |
| Christiansen, GR | 1 |
| Weichert-Jacobsen, K | 2 |
| Schrey, A | 1 |
| Dhabuwala, CB | 1 |
| Kerkar, P | 1 |
| Bhutwala, A | 1 |
| Kumar, A | 1 |
| Pierce, JM | 1 |
| Bardin, ED | 1 |
| Krieger, JN | 1 |
| Wand, H | 1 |
| Stief, CG | 1 |
| Gilbert, P | 1 |
| Wetterhauer, U | 1 |
| Bähren, W | 1 |
| Thon, W | 1 |
| Altwein, JE | 1 |
| Nellans, RE | 1 |
| Ellis, LR | 1 |
| Vapnek, J | 1 |
| Lue, TF | 3 |
| Vailly, B | 1 |
| Rougeron, G | 1 |
| Weill, A | 1 |
| Bollack, C | 1 |
| Rudnick, J | 1 |
| Gorpinchenko, II | 1 |
| Khudaĭberdiev, NA | 1 |
| Buckley, JF | 1 |
| Chapple, CR | 1 |
| McNicholas, T | 1 |
| Zentgraf, M | 1 |
| Ludwig, G | 1 |
| Ziegler, M | 1 |
| Porst, H | 1 |
| van Ahlen, H | 1 |
| Shantha, TR | 1 |
| Finnerty, DP | 1 |
| Rodriquez, AP | 1 |
| Pellerin, JP | 1 |
| Erb, CL | 1 |
| Ayzouki, I | 1 |
| Darewicz, J | 1 |
| Galek, L | 1 |
| Fouda, A | 1 |
| Hassouna, M | 1 |
| Beddoe, E | 1 |
| Kalogeropoulos, D | 1 |
| Binik, YM | 1 |
| Elhilali, MM | 1 |
| Uchida, T | 1 |
| Omata, T | 1 |
| Koshiba, K | 1 |
| Orvis, BR | 1 |
| Levine, SB | 2 |
| Althof, SE | 2 |
| Turner, LA | 1 |
| Risen, CB | 1 |
| Bodner, DR | 2 |
| Kursh, ED | 2 |
| Resnick, MI | 2 |
| Schneider, AW | 1 |
| Busch, R | 1 |
| Gonnermann, D | 1 |
| Klosterhalfen, H | 1 |
| Turner, L | 1 |
| Risen, C | 1 |
| Liu, LH | 2 |
| Girdley, FM | 1 |
| Bruskewitz, RC | 1 |
| Feyzi, J | 1 |
| Graversen, PH | 1 |
| Gasser, TC | 1 |
| Bondil, P | 3 |
| Nguyen Qui, JL | 2 |
| Quadraccia, A | 1 |
| Salvini, A | 1 |
| Cordani, C | 1 |
| Pizzi, P | 1 |
| Bellinzoni, G | 1 |
| Tshipeta, N | 1 |
| Watters, GR | 1 |
| Keogh, EJ | 1 |
| Carati, CJ | 1 |
| Tulloch, AG | 1 |
| Lord, DJ | 1 |
| Corriere, JN | 1 |
| Fishman, IJ | 1 |
| Benson, GS | 1 |
| Carlton, CE | 1 |
| Rigot, JM | 1 |
| Mazeman, E | 1 |
| Liu, LC | 1 |
| Huang, CH | 1 |
| Chiang, CP | 1 |
| Tanagho, EA | 1 |
| Nadig, PW | 1 |
| Halsted, DS | 1 |
| Weigel, JW | 1 |
| Noble, MJ | 1 |
| Mebust, WK | 1 |
| Wyndaele, JJ | 1 |
| de Meyer, JM | 1 |
| de Sy, WA | 1 |
| Claessens, H | 1 |
| Padma-Nathan, H | 1 |
| Goldstein, I | 1 |
| Krane, RJ | 1 |
| Port, FK | 1 |
| Fiegel, P | 1 |
| Hecking, E | 1 |
| Köhler, H | 1 |
| Distler, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sirolimus Eluting Balloon Utilization for Treatment of Vasculogenic Erectile Dysfunction - The SUASION Study[NCT04345965] | 100 participants (Anticipated) | Observational | 2019-09-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for papaverine and Priapism
| Article | Year |
|---|---|
Risk factors for papaverine-induced priapism.
Topics: Adult; Erectile Dysfunction; Humans; Incidence; Male; Middle Aged; Papaverine; Priapism; Risk Factor | 1992 |
How safe is the treatment of impotence with intracavernous autoinjection?
Topics: Drug Combinations; Erectile Dysfunction; Fibrosis; Humans; Male; Papaverine; Penile Erection; Penis; | 1989 |
New therapy for impotence.
Topics: Adrenergic alpha-Antagonists; Animals; Arterial Occlusive Diseases; Erectile Dysfunction; Humans; In | 1987 |
Injection therapy for impotence.
Topics: Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Erectile Dysfunct | 1988 |
8 trials available for papaverine and Priapism
| Article | Year |
|---|---|
The value of penile duplex in the prediction of intracavernous drug-induced priapism.
Topics: Alprostadil; Antihypertensive Agents; Erectile Dysfunction; Humans; Ischemia; Male; Middle Aged; Pap | 2004 |
Oral terbutaline in the management of pharmacologically induced prolonged erection.
Topics: Adrenergic beta-Agonists; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Humans; Injections; Mal | 2004 |
Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects.
Topics: Adrenergic alpha-Antagonists; Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Inject | 2005 |
Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
Topics: Alprostadil; Drug Combinations; Erectile Dysfunction; Fibrosis; Follow-Up Studies; Humans; Injection | 1994 |
[Treatment of impotence with intracavernous auto-injections: moxisylyte diminishes the risks compared to papaverine].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Moxisylyte; Papaverine; Pe | 1993 |
Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Drug Combinations; Erectile Dysfunction; Humans; Impote | 1994 |
Three-year outcome of a progressive treatment program for erectile dysfunction with intracavernous injections of vasoactive drugs.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Follow | 2000 |
Injection therapy for impotence.
Topics: Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Erectile Dysfunct | 1988 |
68 other studies available for papaverine and Priapism
| Article | Year |
|---|---|
Independent Predictive Factors for Occurrence of Ischemic Priapism after Papaverine Injection.
Topics: Adult; Erectile Dysfunction; Humans; Injections, Intralesional; Ischemia; Male; Middle Aged; Papaver | 2020 |
Etiological factors and management in priapism patients and attitude of emergency physicians.
Topics: Adolescent; Adult; Aged; Attitude of Health Personnel; Blood Gas Analysis; Child; Emergency Service, | 2017 |
The actual incidence of papaverine-induced priapism in patients with erectile dysfunction following penile colour Doppler ultrasonography.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Incidence; Male; Middle Aged; Papaverine; Penis; Priapism | 2010 |
The incidence and management of priapism in Western Australia: a 16 year audit.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Drainage; Drug Co | 2003 |
Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
Topics: Adult; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papa | 2003 |
Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction.
Topics: Enzyme Inhibitors; Erectile Dysfunction; Humans; Injections; Male; Methylene Blue; Papaverine; Phent | 2003 |
Intracavernous papaverine/phentolamine-induced priapism can be accurately predicted with color Doppler ultrasonography.
Topics: Adult; Aged; Humans; Male; Middle Aged; Papaverine; Penis; Phentolamine; Predictive Value of Tests; | 2005 |
Intracorporeal phenylephrine in the treatment of priapism.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alprostadil; Blood Pressure; Erectile Dysfu | 1996 |
Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs.
Topics: Adult; Aged; Erectile Dysfunction; Finland; Humans; Male; Middle Aged; Papaverine; Priapism; Punctur | 1995 |
Intracavernous self-injection of papaverine and verapamil: a clinical experience.
Topics: Adult; Aged; Cicatrix; Drug Combinations; Erectile Dysfunction; Hematoma; Humans; Injections; Male; | 1994 |
Management of pharmacologically induced prolonged penile erection with oral terbutaline in traumatic paraplegics.
Topics: Administration, Oral; Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverin | 1994 |
Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism.
Topics: Adrenergic alpha-Agonists; Humans; Injections; Male; Papaverine; Phentolamine; Priapism; Vasoconstri | 1995 |
Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
Topics: Adult; Alprostadil; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Drug Monitoring; Drug Syne | 1994 |
Experience with triple-drug therapy in a pharmacological erection program.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Cicatrix; Costs and Cost Analysis; Drug Combinations; E | 1993 |
Risks of self-injection therapy for impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Priapism; Self Admini | 1996 |
Priapism following ingestion of papaverine tablets.
Topics: Administration, Oral; Adult; Drainage; Humans; Male; Papaverine; Parasympatholytics; Phenylephrine; | 1996 |
Alternative approaches to the management of priapism.
Topics: Adult; Alprostadil; Anemia, Sickle Cell; Embolization, Therapeutic; Enzyme Inhibitors; Guanylate Cyc | 1998 |
The incidence of pharmacologically induced priapism in the diagnostic and therapeutic management of 685 men with erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Dose-Response Relationship, Drug; Erectile Dysfuncti | 2001 |
The prediction of papaverine induced priapism by color Doppler sonography.
Topics: Humans; Male; Papaverine; Predictive Value of Tests; Priapism; Retrospective Studies; Ultrasonograph | 2001 |
[Priapism induced by intracavernous injection].
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papav | 1992 |
Staphylococcal septicaemia complicating intracavernosal autoinjection therapy for impotence in a man with diabetes.
Topics: Bacteremia; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Floxacillin; | 1992 |
Papaverine, benzodiazepines, and prolonged erections.
Topics: Anxiety; Diazepam; Drug Interactions; Humans; Male; Middle Aged; Papaverine; Penile Erection; Priapi | 1991 |
Iatrogenic priapism.
Topics: Benzodiazepines; Erectile Dysfunction; Humans; Male; Papaverine; Priapism | 1991 |
[Psychological factors affect the erectile response to papaverine injection].
Topics: Anxiety; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Priapism | 1991 |
Treatment of pharmacological priapism with phenylephrine.
Topics: Adult; Alprostadil; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phent | 1991 |
Induced priapism and its management.
Topics: Dopamine; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Metaraminol; Pa | 1991 |
[Prolonged erections after diagnostic injection of papaverine chlorhydrate].
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Priapism | 1991 |
Purulent corporeal cavernositis secondary to papaverine-induced priapism.
Topics: Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Induration; Priapism | 1991 |
[Neurotransmitters of penile erection other than vasoactive intestinal polypeptide. Physiologic data and therapeutic consequences].
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Neurotransmitter Agents; Papaverine; Penile Erectio | 1990 |
A lethal complication of papaverine-induced priapism.
Topics: Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Multiple Sclerosis; Papaverine; Penis; | 1991 |
[Management of drug-induced priapism].
Topics: Dopamine; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Humans; Male; Papaver | 1991 |
[Cavernosography using digital luminescence radiography (DLR) in the diagnosis of venous induced erectile function and of diseases of the corpus cavernosum].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Diseases; Penile Er | 1991 |
[Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Induration; Priapism | 1990 |
Intracavernous papaverine in the management of psychogenic impotence.
Topics: Adult; Aged; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Papaverine; Penile | 1990 |
Pharmacological priapism: comparison of trazodone- and papaverine-associated cases.
Topics: Depressive Disorder; Erectile Dysfunction; Humans; Male; Papaverine; Priapism; Trazodone | 1990 |
[Priapism following intracavernous injection of vasoactive substances as a urologic emergency].
Topics: Adult; Aged; Drug Therapy, Combination; Emergencies; Erectile Dysfunction; Humans; Male; Metaraminol | 1990 |
[Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Metaraminol; Papav | 1986 |
Pharmacological erection: diagnosis and treatment applications in 69 patients.
Topics: Drug Combinations; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolam | 1987 |
Heterotopic bone formation in the corpus cavernosum: a complication of papaverine-induced priapism.
Topics: Aged; Erectile Dysfunction; Humans; Injections; Male; Ossification, Heterotopic; Papaverine; Penile | 1989 |
[Epilepsy and hypertensive crisis after intracavernous injection of metaraminol in the treatment of priapism secondary to a papaverine test].
Topics: Epilepsy; Humans; Hypertension; Male; Metaraminol; Middle Aged; Papaverine; Priapism | 1989 |
[Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Defense for the use of facilitating drugs. Part I--Pharmacology, classification and complications of active drugs].
Topics: Adrenergic alpha-Antagonists; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Phenoxyben | 1989 |
[Comment on the contribution by H. Porst and H. van Ahlen. Drug-induced priapism--a report of experiences with 101 cases. Urologe [A] (1989) 28: 84-7].
Topics: Alprostadil; Humans; Male; Papaverine; Phentolamine; Priapism; Risk Factors | 1989 |
[The intracavernosal administration of papaverine in the diagnosis and treatment of sexual disorders in men].
Topics: Adult; Aged; Chronic Disease; Drug Evaluation; Erectile Dysfunction; Hemodynamics; Humans; Injection | 1989 |
Continuous infusion of phenylephrine in the treatment of papaverine-induced priapism.
Topics: Adult; Humans; Male; Papaverine; Phenylephrine; Priapism; Spastic Paraplegia, Hereditary | 1989 |
[Drug-induced priapism--a report of experiences in 101 cases].
Topics: Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In | 1989 |
Treatment of persistent penile erection and priapism using terbutaline.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phenoxybe | 1989 |
[Drug-induced priapism].
Topics: Anticoagulants; Humans; Male; Papaverine; Priapism | 1989 |
[Priapism as a complication following diagnostic papaverine test].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections, Intravenous; Male; Middle Aged; Papaverine; P | 1989 |
Priapism: an avoidable complication of pharmacologically induced erection.
Topics: Humans; Injections; Male; Papaverine; Penile Erection; Penis; Phentolamine; Photic Stimulation; Pria | 1989 |
[Intracavernous injection of etilefrine hydrochloride in iatrogenic priapism].
Topics: Adult; Aged; Etilefrine; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Phenyle | 1986 |
Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Liver Function Tes | 1989 |
[Papaverine-induced priapism. Experiences with a new urologic emergency].
Topics: Adult; Bloodletting; Combined Modality Therapy; Dose-Response Relationship, Drug; Emergencies; Erect | 1989 |
[Diagnostic intracorporeal papaverine injection].
Topics: Adult; Aged; Blood Pressure; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine | 1988 |
Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.
Topics: Consumer Behavior; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Pain; Papaver | 1988 |
Re: Papaverine-induced priapism: 2 case reports.
Topics: Humans; Male; Papaverine; Priapism | 1988 |
[Are intracavernous injections of drugs for impotence harmless?].
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Penis; Priapism | 1988 |
Nocturnal computed rigidity and tumescence evaluation in the prevention of the iatrogenic priapism.
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penil | 1988 |
[Intracavernous papaverine in impotence. Radiographic and manometric studies].
Topics: Adolescent; Adult; Erectile Dysfunction; Humans; Injections; Male; Manometry; Middle Aged; Papaverin | 1988 |
Prolonged erections following intracorporeal injection of medications to overcome impotence.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Metaraminol; Middle Aged; Papaverine; Phenoxybenzam | 1988 |
Development of fibrotic penile lesions secondary to the intracorporeal injection of vasoactive agents.
Topics: Adult; Erectile Dysfunction; Fibrosis; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis | 1988 |
[Intracavernosa injections of drugs in erection disorders. Their clinical value apropos of 100 cases].
Topics: Erectile Dysfunction; Humans; Male; Metaraminol; Papaverine; Penile Erection; Priapism; Vasoconstric | 1987 |
Papaverine-induced priapism: case report.
Topics: Adult; Erectile Dysfunction; Humans; Male; Papaverine; Priapism; Suction | 1987 |
Physiology of erection and pharmacological management of impotence.
Topics: Animals; Drug Combinations; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; | 1987 |
Priapism--a medical emergency.
Topics: Emergencies; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Priapism | 1987 |
Papaverine-induced priapism: 2 case reports.
Topics: Adult; Humans; Male; Papaverine; Priapism | 1986 |
Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
Topics: Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; | 1986 |
Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Phentolamine; Priapism; | 1986 |
Priapism during regular haemodialysis.
Topics: Adult; Chronic Disease; Diazepam; Glomerulonephritis; Heparin; Home Care Services; Humans; Infusions | 1974 |